Zyryanov S.K. - Список публикаций

Список записей

Отображать:

PHARMACOECONOMIC ANALYSIS OF USING BIOLOGICAL AGENTS FOR UNCONTROLLED MODERATE-TO-SEVERE ATOPIC ASTHMA IN THE RUSSIAN FEDERATION

Article

Zyryanov S.K., Diyakov I.N., Avdeev S.N.

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. Том 12. 2019. С. 268-278

THE FIRST RUSSIAN CONSENSUS ON QUANTITATIVE ASSESSMENT OF TREATMENT OUTCOME

Article

Arutyunov A.G., Bojcov S.A., Viktorova I.A., Vlasov V.V., Voevoda M.I., Vorob'yov P.A., Drapkina O.M., Zadionchenko V.S., Zarubina T.V., Zyryanov S.K., Karpov R.S., Kobalava Z.D., Kolbasnikov S.V., Lazebnik L.B., Livzan M.A., Malyavin A.G., Martynov A.I., Medvedeva I.V., Moiseev S.V., Napalkov D.A. ...

Medical News of North Caucasus. Том 14. 2019. С. 283-301

MODERN APPROACHES TO THE RATIONAL CHOICE OF ANTIBIOTIC FOR TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN VARIOUS CATEGORIES OF PATIENTS

Article

Zyryanov S.K., Butranova O.I.

Качественная клиническая практика. 2019. С. 89-105

PREVALENCE OF POTENTIALLY INAPPROPRIATE MEDICATIONS AMONG ELDERLY PATIENTS IN CLINICAL PRACTICE

Article

Al-Rajavi A., Zyryanov S.K., Ushkalova E.A., Butranova O.I., Pereverzev A.P.

Качественная клиническая практика. 2019. С. 57-65

MURAMYLDIPEPTIDE - BASED COMPOUNDS IN CURRENT MEDICINE: FOCUS ON GLUCOSAMINYLMURAMYL DIPEPTIDE

Article

Ushkalova E.A., Zyryanov S.K., Zatolochina K.E.

Terapevticheskii Arkhiv. Том 91. 2019. С. 122-127

DISCREPANCIES IN DRUG LABELING TEXTS AS A CAUSE OF MEDICATION ERRORS

Article

Asetskaya I.L., Polivanov V.A., Zyryanov S.K., Glagolev S.V., Kuzmina A.V.

Вестник Росздравнадзора. 2019. С. 59-62

ECONOMIC PERSPECTIVES FOR EFFECTIVE CONTROL OF DIABETES MELLITUS TYPE 2 WITH FIXED COMBINATION OF BASAL INSULIN ANALOG AND GLP-1 AGONIST

Article

Zyryanov S.K., Dyakov I.N.

Качественная клиническая практика. 2019. С. 4-14

SAFETY AND TOLERABILITY OF NSAIDS: FOCUS ON ACECLOFENAC

Article

Ushkalova E.A., Zyryanov S.K., Zalolochina K.E.

Медицинский совет. 2019. С. 110-120

POTENTIALLY PRESCRIBING OMISSIONS IN ELDERLY PATIENTS: PREVALENCE, RISK FACTORS AND IDENTIFICATION

Article

Al-Ragawi Ali, Zyryanov Sergey

SCIENCE4HEALTH 2019. Клинические и теоретические аспекты современной медицины. 2019. 146 с.

CLINICAL AND ECONOMIC EFFICIENCY OF TREATMENT WITH CARIPRAZINE IN SCHIZOPHRENIA

Article

Dyakov I.N., Zyryanov S.K.

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova. Том 119. 2019. С. 66-77

ANALYSIS OF ADVERSE DRUG REACTIONS IN ELDERLY PATIENTS ACCORDING TO THE DATABASE OF SPONTANEOUS REPORTS

Article

Zatolochina K.E., Ushkalova E.A., Zyryanov S.K., Polivanov V.A.

Хирург. 2019. С. 69-73

SERIOUS ADVERSE DRUG REACTIONS WITH LETHAL OUTCOMES: ANALYSIS OF THE RUSSIAN PHARMACOVIGILANCE DATABASE

Article

Shmaevskij P.E., Kosyakina N., Cigura D.A., Zatolochina K.E., Zyryanov S.K., Asetskaya I.L., Kazakov A.S.

SCIENCE4HEALTH 2019. Клинические и теоретические аспекты современной медицины. 2019. 142 с.

GENERICS AND BIOSIMILARS IN ONCOLOGY

Article

Gopienko I.A., Ushkalova E.A., Zyryanov S.K.

Качественная клиническая практика. 2019. С. 15-22

THE USE OF NEW DOSAGE FORMS OF ANTIBIOTICS AS A WAY TO IMPROVE THE EFFECTIVENESS AND SAFETY OF ANTIBIOTIC THERAPY

Article

Zyryanov S.K., Baibulatova E.A.

Antibiotiki i Khimioterapiya. Том 64. 2019. С. 81-91

DRUG ADJUSTMENT OF MODIFIED RISK FACTORS AS ONE OF THE LEADING STRATEGIES FOR MANAGING PATIENTS WITH CARDIOVASCULAR DISEASES

Article

Zyryanov S.K., Baybulatova E.A.

Медицинский совет. 2019. С. 22-38

Страница 13 из 24. Записи с 181 по 195 из 346

Другие авторы

Velibekov M.C.

Записей: 1

Gorbatenko R.G.

Записей: 11